Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-03

AUTHORS

Kazunori Honda, Kyosuke Takeshita, Kenta Murotani, Ayako Mitsuma, Hironori Hayashi, Nobuyuki Tsunoda, Toyone Kikumori, Toyoaki Murohara, Yuichi Ando

ABSTRACT

BACKGROUND: The ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (e', E/e' ratio) as estimated by tissue Doppler imaging is a noninvasive surrogate for the left ventricular diastolic function. Because diastolic dysfunction usually precedes systolic dysfunction in cardiovascular diseases, we investigated whether monitoring the E/e' ratio can help to predict the risk of trastuzumab-induced cardiotoxicity. METHODS: E/e' ratio on tissue Doppler imaging was retrospectively reviewed to assess its value for early detection of the left ventricular ejection fraction (LVEF) decline in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer who received trastuzumab with or without cytotoxic chemotherapy. Echocardiography was performed at baseline and every 3 months after treatment began. RESULTS: Among 129 patients, LVEF declined in 25 (19 %) during trastuzumab treatment; the decline was grade 2 in 23 patients and grade 3 in 2. Elevation of the E/e' ratio to more than 15 was detected in 17 patients (13 %), 7 of whom (5.4 % of total) concurrently had LVEF decline. A weak negative correlation was observed between E/e' elevation and the worst LVEF decline (P = 0.0077), which was confirmed by multiple regression analysis (P = 0.023). E/e' ratio at baseline or 3 months after beginning trastuzumab treatment was not significantly associated with the subsequent LVEF decline. CONCLUSION: Monitoring of the left ventricular diastolic function on the basis of the E/e' ratio at baseline or 3 months after is unlikely to predict LVEF decline in patients who receive trastuzumab. However, there is a potential chronological relation between E/e' elevation and LVEF decline, implying that the degree of E/e' elevation could have a role as a surrogate marker for predicting the LVEF decline characteristic of trastuzumab-induced cardiotoxicity. More... »

PAGES

312-318

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12282-016-0705-4

DOI

http://dx.doi.org/10.1007/s12282-016-0705-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050681810

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27234030


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiotoxicity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Echocardiography, Doppler", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Trastuzumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Dysfunction, Left", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Function, Left", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai, Showa, 466-8560, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Honda", 
        "givenName": "Kazunori", 
        "id": "sg:person.0770041747.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770041747.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeshita", 
        "givenName": "Kyosuke", 
        "id": "sg:person.01154532160.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154532160.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aichi Medical University", 
          "id": "https://www.grid.ac/institutes/grid.411234.1", 
          "name": [
            "Division of Biostatistics, Clinical Research Center, Aichi Medical University, Nagakute, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murotani", 
        "givenName": "Kenta", 
        "id": "sg:person.01002652037.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002652037.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai, Showa, 466-8560, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitsuma", 
        "givenName": "Ayako", 
        "id": "sg:person.01330454765.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330454765.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hayashi", 
        "givenName": "Hironori", 
        "id": "sg:person.013422067712.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013422067712.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsunoda", 
        "givenName": "Nobuyuki", 
        "id": "sg:person.01270123147.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270123147.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kikumori", 
        "givenName": "Toyone", 
        "id": "sg:person.01344044310.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344044310.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University", 
          "id": "https://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murohara", 
        "givenName": "Toyoaki", 
        "id": "sg:person.01166405657.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166405657.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.437848.4", 
          "name": [
            "Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai, Showa, 466-8560, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ando", 
        "givenName": "Yuichi", 
        "id": "sg:person.013237674417.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013237674417.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.2014-0500", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002350826"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.27.3615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011439502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.13.5467", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011604292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.48.7884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011685659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2012.07.068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024905425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2796.2002.00951.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029817434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-011-1714-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031903711", 
          "https://doi.org/10.1007/s10549-011-1714-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00059-011-3472-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032062469", 
          "https://doi.org/10.1007/s00059-011-3472-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.106.661983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035592167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mds293", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038260596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(84)90695-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040787456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djs317", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041118858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.64.2.315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046372580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.11.0106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047835512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12350-015-0164-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051351056", 
          "https://doi.org/10.1007/s12350-015-0164-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-03", 
    "datePublishedReg": "2017-03-01", 
    "description": "BACKGROUND: The ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (e', E/e' ratio) as estimated by tissue Doppler imaging is a noninvasive surrogate for the left ventricular diastolic function. Because diastolic dysfunction usually precedes systolic dysfunction in cardiovascular diseases, we investigated whether monitoring the E/e' ratio can help to predict the risk of trastuzumab-induced cardiotoxicity.\nMETHODS: E/e' ratio on tissue Doppler imaging was retrospectively reviewed to assess its value for early detection of the left ventricular ejection fraction (LVEF) decline in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer who received trastuzumab with or without cytotoxic chemotherapy. Echocardiography was performed at baseline and every 3\u00a0months after treatment began.\nRESULTS: Among 129 patients, LVEF declined in 25 (19\u00a0%) during trastuzumab treatment; the decline was grade 2 in 23 patients and grade 3 in 2. Elevation of the E/e' ratio to more than 15 was detected in 17 patients (13\u00a0%), 7 of whom (5.4\u00a0% of total) concurrently had LVEF decline. A weak negative correlation was observed between E/e' elevation and the worst LVEF decline (P\u00a0=\u00a00.0077), which was confirmed by multiple regression analysis (P\u00a0=\u00a00.023). E/e' ratio at baseline or 3\u00a0months after beginning trastuzumab treatment was not significantly associated with the subsequent LVEF decline.\nCONCLUSION: Monitoring of the left ventricular diastolic function on the basis of the E/e' ratio at baseline or 3\u00a0months after is unlikely to predict LVEF decline in patients who receive trastuzumab. However, there is a potential chronological relation between E/e' elevation and LVEF decline, implying that the degree of E/e' elevation could have a role as a surrogate marker for predicting the LVEF decline characteristic of trastuzumab-induced cardiotoxicity.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12282-016-0705-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021080", 
        "issn": [
          "1340-6868", 
          "1880-4233"
        ], 
        "name": "Breast Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "name": "Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer", 
    "pagination": "312-318", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f16e081934101bfe0ca62ccb40abe1d09cced48dc3e5ab2c2c51f35419155b7d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27234030"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100888201"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12282-016-0705-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050681810"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12282-016-0705-4", 
      "https://app.dimensions.ai/details/publication/pub.1050681810"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12282-016-0705-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12282-016-0705-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12282-016-0705-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12282-016-0705-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12282-016-0705-4'


 

This table displays all metadata directly associated to this object as RDF triples.

241 TRIPLES      21 PREDICATES      59 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12282-016-0705-4 schema:about N01aee35538bf48159b976e585f8785db
2 N15f90914e31f4b829720b10b541aafb1
3 N218d9abc2c7741f7a305da2e5288c015
4 N29db89eaa4b24c2c8c5509962a496aa0
5 N2eadb56ddde14cb3aa490b7d05020020
6 N382e784d4aff4751ada7493adb35abc5
7 N3e2a6ff5946f4623925ffaec62eb1bdf
8 N4dbdb0dccf764911b3fcd7b6c0330408
9 N5f5f625b179047c6b6a4f4f7a6b17bb3
10 N63a806f8fb5245ebb4e7b294b79e342b
11 N6fc9ae574c114c598f013161762e65d2
12 Na588ab1b95ad48faa1a9e9c8f895fb8a
13 Nb3243933ad1f413292588785e29f307f
14 Nc4065760c3504ebc8a764555520c604d
15 Nf92a4e71699c4bceb531f024777d4cff
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N216651022eaf49a7a30ba9a40c758a51
19 schema:citation sg:pub.10.1007/s00059-011-3472-1
20 sg:pub.10.1007/s10549-011-1714-9
21 sg:pub.10.1007/s12350-015-0164-x
22 https://doi.org/10.1016/0002-9149(84)90695-7
23 https://doi.org/10.1016/j.jacc.2012.07.068
24 https://doi.org/10.1046/j.1365-2796.2002.00951.x
25 https://doi.org/10.1093/annonc/mds293
26 https://doi.org/10.1093/jnci/djs317
27 https://doi.org/10.1161/01.cir.64.2.315
28 https://doi.org/10.1161/circulationaha.106.661983
29 https://doi.org/10.1200/jco.2007.11.0106
30 https://doi.org/10.1200/jco.2007.13.5467
31 https://doi.org/10.1200/jco.2009.27.3615
32 https://doi.org/10.1200/jco.2013.48.7884
33 https://doi.org/10.1634/theoncologist.2014-0500
34 schema:datePublished 2017-03
35 schema:datePublishedReg 2017-03-01
36 schema:description BACKGROUND: The ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (e', E/e' ratio) as estimated by tissue Doppler imaging is a noninvasive surrogate for the left ventricular diastolic function. Because diastolic dysfunction usually precedes systolic dysfunction in cardiovascular diseases, we investigated whether monitoring the E/e' ratio can help to predict the risk of trastuzumab-induced cardiotoxicity. METHODS: E/e' ratio on tissue Doppler imaging was retrospectively reviewed to assess its value for early detection of the left ventricular ejection fraction (LVEF) decline in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer who received trastuzumab with or without cytotoxic chemotherapy. Echocardiography was performed at baseline and every 3 months after treatment began. RESULTS: Among 129 patients, LVEF declined in 25 (19 %) during trastuzumab treatment; the decline was grade 2 in 23 patients and grade 3 in 2. Elevation of the E/e' ratio to more than 15 was detected in 17 patients (13 %), 7 of whom (5.4 % of total) concurrently had LVEF decline. A weak negative correlation was observed between E/e' elevation and the worst LVEF decline (P = 0.0077), which was confirmed by multiple regression analysis (P = 0.023). E/e' ratio at baseline or 3 months after beginning trastuzumab treatment was not significantly associated with the subsequent LVEF decline. CONCLUSION: Monitoring of the left ventricular diastolic function on the basis of the E/e' ratio at baseline or 3 months after is unlikely to predict LVEF decline in patients who receive trastuzumab. However, there is a potential chronological relation between E/e' elevation and LVEF decline, implying that the degree of E/e' elevation could have a role as a surrogate marker for predicting the LVEF decline characteristic of trastuzumab-induced cardiotoxicity.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree false
40 schema:isPartOf N9583bdf8f0184ce38149e7918651ae5b
41 Na4f055ab0cae4ea6b7dcc5f2449e5589
42 sg:journal.1021080
43 schema:name Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer
44 schema:pagination 312-318
45 schema:productId N0f13dde32bcc4db5be7939a888b87b9e
46 N5e0d8023f4164c9781586e5142f0591b
47 Nc22210d7fdd642cdabfaaff646960f1e
48 Nef763ee6c4d04a30aec25cd16140ff47
49 Nfb683d30e90e4146ab24a2324f2f8925
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050681810
51 https://doi.org/10.1007/s12282-016-0705-4
52 schema:sdDatePublished 2019-04-11T01:10
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher Nbc88afbfe6e84e68bffcf8426625bc87
55 schema:url http://link.springer.com/10.1007%2Fs12282-016-0705-4
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N01aee35538bf48159b976e585f8785db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Breast Neoplasms
61 rdf:type schema:DefinedTerm
62 N0f13dde32bcc4db5be7939a888b87b9e schema:name dimensions_id
63 schema:value pub.1050681810
64 rdf:type schema:PropertyValue
65 N15f90914e31f4b829720b10b541aafb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Aged, 80 and over
67 rdf:type schema:DefinedTerm
68 N1a4742fdcb3940e7b89f33ae06786fb1 rdf:first sg:person.01154532160.92
69 rdf:rest Nbc11bdf53c444d9d85809c62a2d972da
70 N216651022eaf49a7a30ba9a40c758a51 rdf:first sg:person.0770041747.73
71 rdf:rest N1a4742fdcb3940e7b89f33ae06786fb1
72 N218d9abc2c7741f7a305da2e5288c015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Female
74 rdf:type schema:DefinedTerm
75 N29db89eaa4b24c2c8c5509962a496aa0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Aged
77 rdf:type schema:DefinedTerm
78 N2eadb56ddde14cb3aa490b7d05020020 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Adult
80 rdf:type schema:DefinedTerm
81 N382e784d4aff4751ada7493adb35abc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Ventricular Dysfunction, Left
83 rdf:type schema:DefinedTerm
84 N3b2fe2e8e79b48118bcddd7e2b0c2dbb rdf:first sg:person.01166405657.56
85 rdf:rest Nafb891c81e8a4e14bc947f178710f117
86 N3e2a6ff5946f4623925ffaec62eb1bdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Cardiotoxicity
88 rdf:type schema:DefinedTerm
89 N4dbdb0dccf764911b3fcd7b6c0330408 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Receptor, ErbB-2
91 rdf:type schema:DefinedTerm
92 N5e0d8023f4164c9781586e5142f0591b schema:name doi
93 schema:value 10.1007/s12282-016-0705-4
94 rdf:type schema:PropertyValue
95 N5f5f625b179047c6b6a4f4f7a6b17bb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Middle Aged
97 rdf:type schema:DefinedTerm
98 N63a806f8fb5245ebb4e7b294b79e342b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Echocardiography, Doppler
100 rdf:type schema:DefinedTerm
101 N6fc9ae574c114c598f013161762e65d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Ventricular Function, Left
103 rdf:type schema:DefinedTerm
104 N7a5229a10701449eb5448ce16dcf18f5 rdf:first sg:person.01330454765.35
105 rdf:rest Ncf0acce2bb3f48b1947d4dd48b3842aa
106 N93c822c4905040838d9c8417ac7039b6 rdf:first sg:person.01344044310.45
107 rdf:rest N3b2fe2e8e79b48118bcddd7e2b0c2dbb
108 N9583bdf8f0184ce38149e7918651ae5b schema:issueNumber 2
109 rdf:type schema:PublicationIssue
110 Na4f055ab0cae4ea6b7dcc5f2449e5589 schema:volumeNumber 24
111 rdf:type schema:PublicationVolume
112 Na588ab1b95ad48faa1a9e9c8f895fb8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Trastuzumab
114 rdf:type schema:DefinedTerm
115 Nafb891c81e8a4e14bc947f178710f117 rdf:first sg:person.013237674417.91
116 rdf:rest rdf:nil
117 Nb3243933ad1f413292588785e29f307f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 Nbc11bdf53c444d9d85809c62a2d972da rdf:first sg:person.01002652037.58
121 rdf:rest N7a5229a10701449eb5448ce16dcf18f5
122 Nbc88afbfe6e84e68bffcf8426625bc87 schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 Nc22210d7fdd642cdabfaaff646960f1e schema:name pubmed_id
125 schema:value 27234030
126 rdf:type schema:PropertyValue
127 Nc4065760c3504ebc8a764555520c604d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Retrospective Studies
129 rdf:type schema:DefinedTerm
130 Nccdc102ebb62455eb7a1716e8a6a9ee9 rdf:first sg:person.01270123147.01
131 rdf:rest N93c822c4905040838d9c8417ac7039b6
132 Ncf0acce2bb3f48b1947d4dd48b3842aa rdf:first sg:person.013422067712.45
133 rdf:rest Nccdc102ebb62455eb7a1716e8a6a9ee9
134 Nef763ee6c4d04a30aec25cd16140ff47 schema:name readcube_id
135 schema:value f16e081934101bfe0ca62ccb40abe1d09cced48dc3e5ab2c2c51f35419155b7d
136 rdf:type schema:PropertyValue
137 Nf92a4e71699c4bceb531f024777d4cff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Antineoplastic Agents
139 rdf:type schema:DefinedTerm
140 Nfb683d30e90e4146ab24a2324f2f8925 schema:name nlm_unique_id
141 schema:value 100888201
142 rdf:type schema:PropertyValue
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
147 schema:name Oncology and Carcinogenesis
148 rdf:type schema:DefinedTerm
149 sg:journal.1021080 schema:issn 1340-6868
150 1880-4233
151 schema:name Breast Cancer
152 rdf:type schema:Periodical
153 sg:person.01002652037.58 schema:affiliation https://www.grid.ac/institutes/grid.411234.1
154 schema:familyName Murotani
155 schema:givenName Kenta
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002652037.58
157 rdf:type schema:Person
158 sg:person.01154532160.92 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
159 schema:familyName Takeshita
160 schema:givenName Kyosuke
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154532160.92
162 rdf:type schema:Person
163 sg:person.01166405657.56 schema:affiliation https://www.grid.ac/institutes/grid.27476.30
164 schema:familyName Murohara
165 schema:givenName Toyoaki
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166405657.56
167 rdf:type schema:Person
168 sg:person.01270123147.01 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
169 schema:familyName Tsunoda
170 schema:givenName Nobuyuki
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270123147.01
172 rdf:type schema:Person
173 sg:person.013237674417.91 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
174 schema:familyName Ando
175 schema:givenName Yuichi
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013237674417.91
177 rdf:type schema:Person
178 sg:person.01330454765.35 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
179 schema:familyName Mitsuma
180 schema:givenName Ayako
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330454765.35
182 rdf:type schema:Person
183 sg:person.013422067712.45 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
184 schema:familyName Hayashi
185 schema:givenName Hironori
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013422067712.45
187 rdf:type schema:Person
188 sg:person.01344044310.45 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
189 schema:familyName Kikumori
190 schema:givenName Toyone
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344044310.45
192 rdf:type schema:Person
193 sg:person.0770041747.73 schema:affiliation https://www.grid.ac/institutes/grid.437848.4
194 schema:familyName Honda
195 schema:givenName Kazunori
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770041747.73
197 rdf:type schema:Person
198 sg:pub.10.1007/s00059-011-3472-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032062469
199 https://doi.org/10.1007/s00059-011-3472-1
200 rdf:type schema:CreativeWork
201 sg:pub.10.1007/s10549-011-1714-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031903711
202 https://doi.org/10.1007/s10549-011-1714-9
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/s12350-015-0164-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051351056
205 https://doi.org/10.1007/s12350-015-0164-x
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/0002-9149(84)90695-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040787456
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/j.jacc.2012.07.068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024905425
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1046/j.1365-2796.2002.00951.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029817434
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1093/annonc/mds293 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038260596
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1093/jnci/djs317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041118858
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1161/01.cir.64.2.315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046372580
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1161/circulationaha.106.661983 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035592167
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1200/jco.2007.11.0106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047835512
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1200/jco.2007.13.5467 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011604292
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1200/jco.2009.27.3615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011439502
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1200/jco.2013.48.7884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011685659
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1634/theoncologist.2014-0500 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002350826
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.27476.30 schema:alternateName Nagoya University
232 schema:name Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.411234.1 schema:alternateName Aichi Medical University
235 schema:name Division of Biostatistics, Clinical Research Center, Aichi Medical University, Nagakute, Japan
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.437848.4 schema:alternateName Nagoya University Hospital
238 schema:name Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan
239 Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan
240 Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai, Showa, 466-8560, Nagoya, Japan
241 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...